<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04133441</url>
  </required_header>
  <id_info>
    <org_study_id>vitDplatelet</org_study_id>
    <nct_id>NCT04133441</nct_id>
  </id_info>
  <brief_title>25-Hydroxyvitamin D Levels Are Negatively Associated With Platelets Number in a Cohort of Overweight and Obese Subjects</brief_title>
  <official_title>25-Hydroxyvitamin D Levels Are Negatively Associated With Platelets Number in a Cohort of Overweight and Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was aimed to investigate the associations between platelet number and 25(OH)D
      serum concentration in apparently healthy but overweight/obese subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects were enrolled at the first examination whether they were not taking any medication,
      including oral contraceptives or drugs for osteoporosis, and free of significant medical
      illnesses, except obesity. Exclusion criteria were history of endocrinological diseases
      (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), chronic inflammatory
      diseases, stable known hypertension, angina pectoris, stroke, transient ischemic attack,
      heart infarction, congenital heart disease, malignancies, chronic inflammatory diseases,
      renal and liver failure, angina pectoris, myocardial infarction, heart failure, congenital
      heart diseases, minor and major stroke, and inherited thrombocytopenias and other major
      malignancies. subjects were examined by means of the medical history, hormonal, metabolic and
      routine hematochemical parameters. We provided for a clinical baseline evaluation that
      included extemporaneous ambulatory blood pressure (BP) and a physical assessment of body
      weight, Body Mass Index (BMI) and Waist Circumference (WC) as anthropometric parameters. To
      lead the statistical analysis, all sample was clusterized into three different groups
      according to the diagnostic condition of deficiency (&lt;10 ng/mL), insufficiency (&lt;20 ng/mL)
      and sufficiency (â‰¥20 ng/mL) of vitamin D. We labelled each cluster as group 1, group 2 and
      group 3.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>At baseline</time_frame>
    <description>Vitamin D (ng/mL) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelets</measure>
    <time_frame>At baseline</time_frame>
    <description>Platelets (cells/mm3) number in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>At baseline</time_frame>
    <description>Insulin (mIU/L) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eGFR (estimated glomerular filtration rate)</measure>
    <time_frame>At baseline</time_frame>
    <description>eGFR (ml/min/1.73 mq)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinin</measure>
    <time_frame>At baseline</time_frame>
    <description>Creatinin (mg/dl) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>Total cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thyroid hormones (FT3, FT4)</measure>
    <time_frame>At baseline</time_frame>
    <description>FT3 (pg/mL), FT4 (pg/mL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>HDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>At baseline</time_frame>
    <description>LDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TSH</measure>
    <time_frame>At baseline</time_frame>
    <description>TSH (mU/L) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>At baseline</time_frame>
    <description>BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>At baseline</time_frame>
    <description>Height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>At baseline</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <enrollment type="Actual">341</enrollment>
  <condition>Obesity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who came to the Outpatient Clinic of Nutrition at the National Institute of
        Gastroenterology &quot;S. de Bellis,&quot; Research Hospital, Castellana Grotte, Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI&gt; 25 Kg/m2)

        Exclusion Criteria:

          -  Any kind of drug

          -  Hypertension

          -  Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism,
             etc.),

          -  Chronic inflammatory diseases

          -  Renal failure

          -  Liver failure

          -  Angina pectoris

          -  Myocardial infarction and heart failure

          -  Genetic heart diseases

          -  Thrombocytopenias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Gastroenterology IRCCS S. de Bellis</name>
      <address>
        <city>Castellana Grotte</city>
        <state>Bari</state>
        <zip>70013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Gianluigi Giannelli</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

